BNC was chosen for its expertise in commercialising nanotechnology products in the life sciences sectors to support the NanoKTN in developing the UK’s bionano & nanomedicine network. The NanoKTN supported the exploitation and commercialisation of micro and nanotechnologies (MNT) by informing, facilitating innovation and encouraging collaborations between suppliers and users.
Under the programme, BNC developed the Nano4Life conference in collaboration with the Wellcome Trust to bring the UK community together. This event has lead to the formation of four Focus Groups for the NanoKTN, namely:
The NanoKTN also provided events, networking opportunities, access to the UK’s MNT Directory plus relevant news and announcements on funding opportunities.